B-type natriuretic peptide is predictive of hospitalization in community-dwelling elderly without heart diseases

Geriatrics and Gerontology International

Volumn 9, Issue 2, 2009, Pages 148-154

  Shimizu, Yuji ^a   Nishinaga, Masanori ^a   Takata, Jun ^a   Miyano, Ichiro ^a   Okumiya, Kiyohito ^b   Matsubayashi, Kozo ^b   Ozawa, Toshio ^c   Yasuda, Nobufumi ^a   Doi, Yoshinori ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

B type natriuretic peptide; Community dwelling elderly; Hospitalization

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C;

AGED; ANAMNESIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMMUNITY CARE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MINI MENTAL STATE EXAMINATION; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HEART DISEASES; HOSPITALIZATION; HUMANS; JAPAN; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS;

EID: 66049137631     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00514.x     Document Type: Article

References (34)

1. Health, Labor and Welfare Ministry. The Heisei 13 (2001) Fiscal Year Version. Tokyo, Japan, 2001.
2. Reuben DB, Ix JH, Greendale GA, Seeman TE. The predictive value of combined hypoalbuminemia and hypocholesterolemia in high functioning community-dwelling older persons: MacArthur studies of successful aging. J Am Geriatr Soc 1999; 47: 402-406.
3. Okamura T, Hayakawa T, Hozawa A et al. Lower levels of serum albumin and total cholesterol associated with decline in activities of daily living and excess mortality in a 12-year cohort study of elderly Japanese. J Am Geriatr Soc 2008; 56: 529-535.
4. Auyeung TW, Lee JS. Prognostic significance of admission electrolyte disturbances in older people: A retrospective cohort study. Geriatr Gerontol Int 2007; 7: 110-113.
5. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
6. Mukoyama M, Nakao K, Hosoda K et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412.
7. Wang TJ, Larson MG, Levy D et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-663.
8. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005; 293: 1609-1616.
9. Wallén T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997; 77: 264-267.
10. Ueda R, Yokouchi M, Suzuki T, Otomo E, Katagiri T. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med 2003; 114: 266-270.
11. Knight EL, Kiely DK, Fish LC, Marcantonio ER, Minaker KL. Atrial natriuretic peptide level contributes to a model of future mortality in the oldest old. J Am Geriatr Soc 1998; 46: 453-457.
12. Witham MD, Gillespie ND, Hutcheon SD, Struthers AD, McMurdo ME. B-type natriuretic peptide is associated with mortality in older functionally impaired patients. J Am Geriatr Soc 2005; 53: 1991-1995.
13. Heidenreich PA, Gubens MA, Fonarow GC, Konstam MA, Stevenson LW, Shekelle PG. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. J Am Coll Cardiol 2004; 43: 1019-1026.
14. Nakamura M, Endo H, Nasu M, Arakawa N, Segawa T, Hiramori K. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 2002; 87: 131-135.
15. Matsubayashi K, Okumiya K, Osaki Y, Fujisawa M, Doi Y. Frailty in elderly Japanese. Lancet 1999; 353: 1445.
16. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Md State Med J 1965; 14: 61-65.
17. McDonagh TA, Robb SD, Murdoch DR et al. Biochemical detection of left ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
18. Lubien E, DeMaria A, Krishnaswamy P et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
19. Dahlström U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 2004; 6: 281-287.
20. Detaint D, Messika-Zeitoun D, Avierinos JF et al. B-type natriuretic peptide in organic mitral regurgitation: Determinants and impact on outcome. Circulation 2005; 111: 2391-2397.
21. Bergler-Klein J, Klaar U, Heger M et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109: 2302-2308.
22. Kupari M, Turto H, Lommi J. Diagnosing heart failure in aortic valve stenosis. J Intern Med 2004; 256: 381-387.
23. Nagaya N, Nishikimi T, Uematsu M et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-870.
24. Maron BJ, Tholakanahalli VN, Zenovich AG et al. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 2004; 109: 984-989.
25. Sayama H, Nakamura Y, Saito N, Kinoshita M, Suda M. Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects. Gerontology 2000; 46: 71-77.
26. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: A community-based study. Circulation 2004; 109: 3176-3181.
27. Ariyarajah V, Apiyasawat S, Najjar H, Mercado K, Puri P, Spodick DH. Frequency of interatrial block in patients with sinus rhythm hospitalized for stroke and comparison to those without interatrial block. Am J Cardiol 2007; 99: 49-52.
28. Igarashi Y, Kashimura K, Makiyama Y, Sato T, Ojima K, Aizawa Y. Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Jpn Circ J 2001; 65: 788-792.
29. Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 2000; 64: 765-771.
30. Gunstad J, Poppas A, Smeal S et al. Relation of brain natriuretic peptide levels to cognitive dysfunction in adults >55 years of age with cardiovascular disease. Am J Cardiol 2006; 98: 538-540.
31. Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DR, MacGregor GA. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clinical Science 1992; 83: 437-444.
32. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 1995; 44 (Suppl 1): S61-64.
33. Giannelli SV, Patel KV, Windham BG, Pizzarelli F, Ferrucci L, Guralnik JM. Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc 2007; 55: 816-823.
34. Shlipak MG, Stehman-Breen C, Fried LF et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 2004; 43: 861-867.